Skip to main content
Fig. 2 | Neurological Research and Practice

Fig. 2

From: Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept study

Fig. 2

Hypothetical simulated activity course of a study patient. The simulated graph shows a hypothetical example of the 7 day rolling average of step counts for a study patient over the course of 6 months with an intravenous immunoglobulins (IVIG) treatment interval of 6 weeks. One hypothesis this study aims to clarify is whether smartwatch-obtained high-frequency measurements might be able to reflect patient-reported end-of-dose phenomena or treatment-related fluctuations. Shortly after the administration of IVIG, the patient's activity might initially increase until it drops again later in the treatment cycle

Back to article page